MacroGenics
MGNX
#8491
Rank
C$0.26 B
Marketcap
C$4.10
Share price
-2.91%
Change (1 day)
31.43%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.37 Billion

According to MacroGenics's latest financial reports the company's total assets are C$0.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$0.37 B-5.14%
2023-12-31C$0.39 B4%
2022-12-31C$0.38 B-10.92%
2021-12-31C$0.42 B-11.53%
2020-12-31C$0.48 B18.32%
2019-12-31C$0.40 B-9.79%
2018-12-31C$0.45 B-3.75%
2017-12-31C$0.47 B12.38%
2016-12-31C$0.41 B-16.07%
2015-12-31C$0.49 B146.98%
2014-12-31C$0.20 B50.71%
2013-12-31C$0.13 B150.52%
2012-12-31C$53.44 M-16.17%
2011-12-31C$63.75 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
C$285.93 B 76,989.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$154.07 B 41,440.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$123.47 B 33,191.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$80.18 B 21,517.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$177.45 B 47,744.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$123.33 B 33,153.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$1.19 B 220.88%๐Ÿ‡บ๐Ÿ‡ธ USA